Address

Atlas Venture
25 First Street
Suite 303
Cambridge, MA 02141
United States

Open map


Recent investment activity

KANDO id: 24121

Corporate information

Founders
Registration country

Company type

Early-stage venture capital firm that creates and invests in biotechnology startup companies in the US.

Funding rounds

Top investment portfolio themes

Actual initial investment stage
N/A (53)
Series A (28)
Seed (9)
Other (1)

Investment activity status
Active investor

Selected investments

Displaying 51 - 75 of 117
Profile Country Date Sort ascending Funding
Mascoma Corp A biofuel company that develops innovative technology for the low-cost conversion of abundant biomass to renewable fuels and chemicals. N/A Initial investment 30,000,000 (USD 30,000,000)
3V Transaction Services Ltd Pay-as-you-go credit card voucher company. Series A Initial investment
Zafgen Inc The world’s first biopharmaceutical company dedicated to developing novel obesity therapeutics. Series A Initial investment 5,180,000 (USD 5,180,000)
Ubiquisys Ltd Developer of convergence solutions that enable mobile operators to speed up and fully benefit from fixed mobile substitution Series A Initial investment
Liquid Machines Inc Series C Initial investment
Dailymotion SA A web video portal for members to see, create, and share online videos. Series A Initial investment 9,500,000 (USD 9,500,000)
Seatwave Ltd Online marketplace where fans can buy and sell tickets for concerts, theatre, sports and just about any other live event. Series A Initial investment 3,000,000 (USD 3,000,000)
SimpleTuition Inc Provider of a Web-based student loan comparison solution by presenting loan details from various lenders. Series A Initial investment 4,400,000 (USD 4,400,000)
MOO Print Ltd A pioneer in web-to-print technology. Series A Initial investment 5,000,000 (USD 5,000,000)
Egalet Ltd A specialty pharma company focusing on pain management. N/A Initial investment 27,600,000 (USD 27,600,000)
InfaCare Pharmaceutical Corp A privately held pediatric-focused specialty pharmaceutical company. Series A Initial investment 30,000,000 (USD 30,000,000)
Veracode Inc Provider of the world’s leading Application Risk Management Platform. N/A Initial investment 7,500,000 (USD 7,500,000)
Kalido Inc The leading provider of business-driven data governance software. Series C Initial investment 13,500,000 (USD 13,500,000)
Bit9 Inc Market leader in adaptive application whitelisting. Series A Initial investment 6,000,000 (USD 6,000,000)
Zinwave Ltd Global provider of reliable in-building wireless coverage solutions Series A Initial investment 7,640,000 (USD 7,640,000)
Ellacoya Networks Inc N/A Initial investment
PicoChip Designs Ltd Develops reprogrammable chips for the WCDMA (3G) and WiMAX markets. Series C Initial investment 20,500,000 (USD 20,500,000)
Pixtronix Inc An emerging company that develops display technologies optimized for portable multimedia devices. Series A Initial investment 3,000,000 (USD 3,000,000)
Globoforce Inc Provider of on-demand employee recognition software solutions. Series B Initial investment 9,300,000 (USD 9,300,000)
Active Endpoints Inc Business process management software. Series A Initial investment
Helicos BioSciences Corp A pioneer in high-speed, high-sensitivity DNA sequencing. N/A Initial investment 27,000,000 (USD 27,000,000)
Cellzome AG A drug discovery and development company and a leader in the use of chemical proteomics technologies. Series C Initial investment 30,000,000
Archemix Corp A biotechnology company, engages in discovering, developing, and commercializing aptamer therapeutics for the treatment of life threatening diseases. N/A Initial investment
The Industree BV Broadband access equipment company. N/A Initial investment
Phase Forward Inc N/A Initial investment

Current team

Past employees

Selected Products / Customers

Financials